Bangladesh's first homegrown COVID vaccine: Globe Biotech Bangavax gets clearance for human trials
The vaccine can reportedly be stored at a temperature of 4 degrees Celsius for one month and of minus 20 degrees Celsius for up to six months.;
Advertisement
Dhaka: Bangladesh's first homegrown COVID-19 vaccine has obtained clearance for human trial in phase I.
The Bangavax vaccine, developed by local pharmaceutical company Globe Biotech, on Sunday received clearance from the Directorate General of Drug Administration under the Ministry of Health and Family Welfare after the relevant authorities reviewed all the documents on all the previous trials.
"We've got the approval for phase I clinical trial of Bangavax," Mohammad Mohiuddin, a senior official at Globe Biotech, told reporters.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.